U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT07509996) titled 'Risk Factors Affecting Growth in Thalassemic Children at AUCH' on March 28.
Brief Summary: Thalassemia major is a hereditary hemoglobinopathy characterized by ineffective erythropoiesis and severe anemia, necessitating lifelong blood transfusions(1,2). Regular transfusions lead to iron overload, a primary driver of growth retardation in affected children. Iron accumulation in tissues like the pituitary and liver disrupts growth hormone secretion and insulin-like growth factor-1 production.
Study Start Date: April 01
Study Type: OBSERVATIONAL
Condition:
Thalassemia Majors (Beta-Thalassemia Major)
Intervention:
OTHER: Non-interv...